Recombinant Human GIPR N-ECD

Este producto es parte de GIP - Gastric inhibitory polypeptide ( Receptor)
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Recombinant Human GIPR N-ECD
category
Proteins and Peptides
provider
FineTest
reference
Pr22688
tested applications
Western Blot, ELISA

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Host
Mammalian Cells
Reactivity
Human
Assay Data
Centrifuge the vial at 10000 rpm for 30 s before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/ml by gently pipetting 2-3 times, don't vortex.
Recommended Dilution
¥
Isotype
¥
Clone ID
¥
Observed MW
17-30 kDa
Expression
Arg22-Gln138
Purity
Greater than 95% as determined by SDS-PAGE.
Size 1
10μg
Size 2
50μg
Size 3
500μg
Size 4
1mg
Form
Lyophilized powder
Tested Applications
Western Blot, ELISA
Buffer
Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Availability
7 days
Storage
The lyophilized protein is stable at -20°C for up to 1 year. After reconstitution, the protein solution is stable at -20 to -80°C for 3 months or 1 week at 2 to 8°C under sterile conditions. For extended storage, it is recommended to further dilute in working aliquots, avoid repeated freeze/thaw cycle.
UniProt ID
P48546
Alias
PGQTL2,Gippr,GIP-R
Background
Protein GIPR
Status
RUO
Note
Endotoxin: < 1 EU/µg as determined by LAL test.
Tag : C-terminal His Tag

Related Products

Pr22688

Recombinant Human GIPR N-ECD

Ver Producto
abx015492

Gastric Inhibitory Polypeptide Receptor (GIPR) Antibody

Rabbit polyclonal antibody against GIPR protein. Immunogen region is Internal.

Ver Producto
abx033435

Gastric Inhibitory Polypeptide Receptor (GIPR) Antibody

GIPR also called glucose-dependent insulinotropic polypeptide, is a 42-amino acid polypeptide synthesized by K cells of the duodenum and small intestine. This protein was originally identified as an activity in gut extracts that inhibited gastric acid secretion and gastrin release, but subsequently was demonstrated to stimulate insulin release potently in the presence of elevated glucose. The insulinotropic effect on pancreatic islet beta-cells was then recognized to be the principal physiologic action of GIP. Together with glucagon-like peptide-1, GIP is largely responsible for the secretion of insulin after eating. The protein is involved in several other facets of the anabolic response.

Ver Producto